29.85
0.30 (1.02%)
| Previous Close | 29.55 |
| Open | 29.75 |
| Volume | 43,896 |
| Avg. Volume (3M) | 49,600 |
| Market Cap | 250,027,984 |
| Price / Earnings (TTM) | 31.76 |
| Price / Earnings (Forward) | 27.70 |
| Price / Sales | 3.88 |
| Price / Book | 5.42 |
| 52 Weeks Range | |
| Earnings Date | 10 Feb 2026 |
| Profit Margin | 11.65% |
| Operating Margin (TTM) | 13.64% |
| Diluted EPS (TTM) | 0.790 |
| Quarterly Revenue Growth (YOY) | 13.10% |
| Quarterly Earnings Growth (YOY) | 26.70% |
| Total Debt/Equity (MRQ) | 0.25% |
| Current Ratio (MRQ) | 5.19 |
| Operating Cash Flow (TTM) | 12.02 M |
| Levered Free Cash Flow (TTM) | 12.07 M |
| Return on Assets (TTM) | 11.04% |
| Return on Equity (TTM) | 16.56% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Medical Devices (US) | Mixed | Mixed |
| Medical Devices (Global) | Mixed | Mixed | |
| Stock | Electromed, Inc. | Mixed | - |
AIStockmoo Score
| Analyst Consensus | NA |
| Insider Activity | NA |
| Price Volatility | -0.5 |
| Technical Moving Averages | 2.5 |
| Technical Oscillators | 2.0 |
| Average | 1.33 |
|
Electromed, Inc. develops, manufactures, markets, and sells airway clearance therapy and related products that apply high frequency chest wall oscillation (HFCWO) therapy in pulmonary care for patients of various ages in the United States and internationally. The company offers SmartVest airway clearance system; SmartVest SQL System that consists of an inflatable therapy garment, a programmable air pulse generator, and a patented single-hose that delivers air pulses from the generator to the garment; and SmartVest Connect, a wireless technology with personalized HFCWO therapy management portal for patients with compromised pulmonary function. It also provides single patient use SmartVest and SmartVest Wrap products for health care providers in the acute care setting. The company offers its products primarily to home health care and institutional markets for patients with bronchiectasis, cystic fibrosis, and neuromuscular diseases. It markets its products primarily to physicians and health care providers, as well as directly to patients. Electromed, Inc. was incorporated in 1992 and is headquartered in New Prague, Minnesota. |
|
| Sector | Healthcare |
| Industry | Medical Devices |
| % Held by Insiders | 20.96% |
| % Held by Institutions | 51.63% |
Ownership
| Name | Date | Shares Held |
|---|---|---|
| Hunter Associates Investment Management Llc | 30 Sep 2025 | 117,750 |
No data within this time range.
No data within this time range.
| Date | Type | Details |
|---|---|---|
| 27 Jan 2026 | Announcement | Electromed, Inc. to Report Q2 Fiscal 2026 Financial Results on February 10, 2026 |
| 20 Nov 2025 | Announcement | Electromed, Inc. to Participate in Noble Capital Markets' 21st Annual Emerging Growth Equity Conference |
| 12 Nov 2025 | Announcement | Electromed, Inc. Announces First Quarter Fiscal 2026 Results |
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2026 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |